The 2nd annual International Congress on Oncology Pathology™: Towards Harmonization of Pathology and Oncology Standards will provide the latest information on key topics in pathology that can readily be applied to clinical practice in a variety of settings. This event will bring together oncologists and pathologists to facilitate awareness of recent advancements in the field of cancer pathology and enhance multidisciplinary collaboration. Leading experts will address critical topics in pathology screening for malignancies commonly encountered in clinical practice. From a foundation of tumor-specific discussions, our clinical experts will appraise clinical guidelines, explore new concepts and clinical research, and address obstacles to optimizing practice. This will be a dynamic experience, allowing participants to engage with faculty as they share their perspectives and personal experiences on clinical challenges and ongoing controversies in the field of pathology. A variety of formats will be used to generate an exciting learning environment, including cutting-edge lectures, panel discussions, multidisciplinary tumor boards, and interactive question-and-answer sessions.
This educational program is directed toward pathologists and oncologists interested in the management of patients with cancer. Fellows, residents, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of patients with cancer are also invited to attend.
Upon completion of this activity, participants should have improved their ability to:
Identify recent advancements to understand current and emerging biomarkers among commonly-encountered malignancies
Analyze pathology-associated disparities and variances in care for patients with cancer
Apply current clinical evidence and evolving guidelines in cancer pathology to the tailoring of patient testing and treatment protocols
Formulate multidisciplinary strategies to optimize cancer diagnosis and management
Outline the roles of genomic and targeted assays in management of patients with cancer